XRPL patches critical flaw before mainnet
The XRP Ledger Foundation said it has patched a critical vulnerability in a yet-to-be-enabled amendment to Ripple’s XRP Ledger, preventing what could have been a major exploit before deployment on mainnet.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
The XRP Ledger Foundation said it has patched a critical vulnerability in a yet-to-be-enabled amendment to Ripple’s XRP Ledger, preventing what could have been a major exploit before deployment on mainnet.
Compañia de Minas Buenaventura (NYSE:BVN), Peru’s largest publicly traded precious metals miner, reported a substantial increase in fourth-quarter and full-year 2025 profitability, bolstered by a strategic shift toward polymetallic production and improved margins.
Ransomware attacks increased sharply in 2025, with nearly 8,000 public leak events recorded, a 50% jump from 2024, according to a new report by Chainalysis.
More than $8.72 billion in Bitcoin and Ethereum options expire today, marking February’s largest derivatives event and covering roughly 20% of total open interest.
Indiana lawmakers have passed House Bill 1042, sending the crypto rights legislation to Governor Mike Braun after it cleared both chambers by a 59–33 vote.
Decentralised perpetual futures exchange Grvt has integrated the Aave lending protocol to allow traders to earn yield on margin collateral while keeping derivatives positions open.
Christopher Alexander Delgado, former chief executive of Goliath Ventures, has been arrested on federal charges of wire fraud and money laundering over an alleged $328 million crypto Ponzi scheme.
Mesoblast (ASX:MSB) logged total revenue surged to US$51.3 million in H1 FY26, an increase from the US$3.2 million recorded in the prior year period.
Block (ASX:XYZ) revealed plans to transition into a "smaller, faster, intelligence-native" organisation—a strategy that involves slashing its workforce by 40%.
Neurizon Therapeutics (ASX:NUZ) commenced dosing for NUZ-001 within the HEALEY ALS platform trial.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy